Cardiotoxicity of Selected Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Renal Cell Carcinoma

Renal cell carcinoma (RCC) is one of the most frequent malignant neoplasms of the kidney. The therapeutic options available for the treatment of advanced or metastatic RCC include vascular endothelial growth factor receptor (VEGFR)-targeted molecules, for example, tyrosine kinase inhibitors (TKI). V...

Descripción completa

Detalles Bibliográficos
Autores principales: Franczyk, Beata, Rysz, Jacek, Ławiński, Janusz, Ciałkowska-Rysz, Aleksandra, Gluba-Brzózka, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855533/
https://www.ncbi.nlm.nih.gov/pubmed/36672689
http://dx.doi.org/10.3390/biomedicines11010181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855533/
https://www.ncbi.nlm.nih.gov/pubmed/36672689
http://dx.doi.org/10.3390/biomedicines11010181

Ejemplares similares